Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.19
Delayed Data
As of Jun 22
 +0.03 / +2.59%
Today’s Change
0.73
Today|||52-Week Range
8.49
-5.56%
Year-to-Date
No recent news for Novavax Inc.

Today’s Trading

Previous close1.16
Today’s open1.18
Day’s range1.17 - 1.22
Volume4,824,978
Average volume (3 months)6,603,630
Market cap$336.3M
Dividend yield--
Data as of 06/22/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.40%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...+0.07+2.58%
BTXBioTime Inc+0.17+5.70%
NSTGNanoString Technolog...+0.15+0.94%
AGENAgenus Inc+0.09+2.28%
Data as of 06/22/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts